CRP and chronic kidney disease: Ravani et al. reported that 25(OH)D was an independent predictor of disease progression and death in patients with stage 2–5 CKD, even after adjusting for age, heart failure, smoking, C-reactive protein, albumin, phosphate, use of converting enzyme inhibitors or angiotensin receptor blockers, and eGFR [41].